Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Detecting and responding to hypoxia.

Hao Zhu1, Tim Jackson, H Franklin Bunn

  • 1Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|January 29, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic potential of the latest oxygen affinity-modifying agent, GBT021601, for treating sickle cell disease is questionable.

British journal of haematology·2024
Same author

Oxygen Delivery in the Treatment of Anemia.

The New England journal of medicine·2022
Same author

Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease.

The New England journal of medicine·2021
Same author

Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin.

Blood·2021
Same author

Predictive modeling of estrogen receptor agonism, antagonism, and binding activities using machine- and deep-learning approaches.

Laboratory investigation; a journal of technical methods and pathology·2020
Same author

Isolation and characterization of multidrug-resistant Klebsiella pneumoniae from raw cow milk in Jiangsu and Shandong provinces, China.

Transboundary and emerging diseases·2020

Hypoxia adaptation involves oxygen sensing and signal transduction, activating hypoxia-inducible transcription factor 1 (HIF-1). A novel flavohaem protein, cytochrome b5/b5 reductase, is identified as a potential oxygen sensor regulating HIF-1 alpha degradation.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Physiology

Background:

  • Hypoxia adaptation is clinically relevant, impacting anemia, ischemia, and cancer.
  • Genes like erythropoietin and vascular endothelial growth factor are regulated by oxygen levels.
  • Erythropoietin gene regulation reveals oxygen sensing and signal transduction mechanisms activating hypoxia-inducible transcription factor 1 (HIF-1).

Purpose of the Study:

  • To elucidate the mechanism of oxygen sensing and signal transduction in hypoxia adaptation.
  • To identify the molecular components involved in regulating hypoxia-inducible transcription factor 1 (HIF-1) activity.
  • To investigate the role of novel proteins in oxygen homeostasis.

Main Methods:

  • Studied erythropoietin gene regulation under hypoxic conditions.

Related Experiment Videos

  • Investigated the activation pathway of hypoxia-inducible transcription factor 1 (HIF-1).
  • Cloned and characterized a novel flavohaem protein, cytochrome b5/b5 reductase.

    • Main Results:

    • Hypoxia activates HIF-1 by stabilizing its alpha-subunit, which translocates to the nucleus.
    • HIF-1 forms a complex with HNF-4 and p300 to activate erythropoietin gene transcription.
    • A novel flavohaem protein, cytochrome b5/b5 reductase, identified as a potential oxygen sensor, may target HIF-1 alpha for degradation.

    Conclusions:

    • The study reveals key molecular players in hypoxia adaptation and HIF-1 activation.
    • Cytochrome b5/b5 reductase is proposed as a novel oxygen sensor involved in regulating HIF-1 alpha stability.
    • Understanding these mechanisms has implications for treating hypoxia-related diseases.